脑部放疗,上午比下午敏感许多!$ _5 y9 S1 b- p& i J
( x* k( \ D' C$ m* r" Y# A
$ L7 e2 m! P8 {0 u7 p" y$ l* T5 `
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
$ O$ ~+ T2 W$ ~" F6 I( EGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?. e& u6 O8 f. w [1 @
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.7 S, B+ I& u2 q+ e. v: c3 {
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.# a& V0 ?& V% _% |6 a0 C
; d7 [, U n( }4 i0 Y% e% _
Abstract
4 D( F* i& A% W* V+ ]BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.; J5 t- n+ a" I0 i; t" P
8 O( A% e, v4 V; Y1 NMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
: |" K7 T- n6 Z) K* O0 ~
' u V7 o& A/ I, l) h4 lRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
8 w) b2 d& s7 x# I# D$ S4 |+ B
4 i! {0 e; g8 R* ^2 |0 NCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.! ^0 U3 N$ P$ t1 v S4 K
: ?3 q" ?: Y) f( X# m
|